Expression of E-cadherin, α-catenin, β-catenin, and γ-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: An immunohistochemical study

Modern Pathology

Volumn 11, Issue 11, 1998, Pages 1039-1045

  Hidaka, Noriko ^a   Nagao, Toshitaka ^a   Asoh, Akira ^a   Kondo, Yoichiro ^b   Nagao, Koichi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catenin; Catenin; Catenin; Bronchioloalveolar carcinoma; E Cadherin; Ki 67

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CELL ADHESION MOLECULE; KI 67 ANTIGEN; PLAKOGLOBIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ALPHA CATENIN; BETA CATENIN; CADHERINS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG; LUNG NEOPLASMS; TRANS-ACTIVATORS;

EID: 0031728361     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Espinoza CG, Balls JU, Saba SR, Paciga JE, Shelley SA. Ultrastructural and immunohistochemical studies of bronchioloalveolar carcinoma. Cancer 1984;54:2182-9.
2. Grigioni WF, Biagini G, Garbisa S, D'Errico A, Milani M, Mastrorilli M, et al. Immunohistochemical study of basement membrane antigens in bronchioloalveolar carcinoma. Am J Pathol 1987;128:217-24.
3. Clayton F. Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer 1986;57: 1555-64.
4. Barsky SH, Grossman DA, Ho J, Holmes EC. The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Mod Pathol 1994;7:633-40.
5. Ohori NP, Yousem SA, Griffin J, Stanis K, Stetler-Stevenson WG, Colby TV, et al. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Am J Surg Pathol 1992;16:675-86.
6. Kodama T, Kameya T, Shimosato Y, Koketsu H, Yoneyama T, Tamai S. Cell incohesiveness and pattern of extension in a rare case of bronchioloalveolar carcinoma. Ultrastruct Pathol 1980;1:177-88.
7. Ohori NP, Coppola D, Landreneau RJ. CD44v6 expression in primary bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. Mod Pathol 1996;9:507-12.
8. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57.
9. Hiscox S, Jiang WG. Expression of E-cadherin, α-, β- and γ-catenin in human colorectal cancer. Anticancer Res 1997; 17:1349-54.
10. Ross JS, del Rosario AD, Figge HL, Sheehan C, Fisher HA, Bui HX. E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. Hum Pathol 1995;26: 940-4.
11. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, et al. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 1994;54:291-6.
12. Hunt NC, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 1997;430:285-9.
13. Bongiorno PF, al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, et al. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 1995;71:166-72.
14. Bohm M, Totzeck B, Birchmeier W, Wieland I. Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer. Clin Exp Metastasis 1994;12: 55-62.
15. Sulzer MA, Leers MP, van Noord JA, Bollen EC, Theunissen PH. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Cell Mol Biol 1998;157:1319-23.
16. Barkely JE, Green MR. Bronchioloalveolar carcinoma. J Clin Oncol 1996;14:2377-86.
17. Daly RC. Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg 1991;51:368-76.
18. Silver SA. True papillary carcinoma of the lung. Am J Surg Pathol 1997;21:43-51.
19. Axiotis CA, Jennings TA. Observations on bronchioloalveolar carcinomas with special emphasis on localized lesions: a clinicopathological, ultrastructural, and immunohistochemical study of 11 cases. Am J Surg Pathol 1988;12:918-31.
20. Manning JT, Spjut HJ, Tschen JA. Bronchioloalveolar carcinoma: the significance of two histopathologic types. Cancer 1984;54:525-34.
21. Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988;23:361-94.
22. Donovan WD, Yankelevitz DF, Henschke CI, Altorki N, Nash TA. Endobronchial spread of bronchioloalveolar carcinoma. Chest 1993;104:951-3.
23. Ferraro L, Sous R, Khan MA. Endobronchial spread of bronchoalveolar cell carcinoma. Chest 1994;105:1627-8.
24. De Leeuw WJ, Berx G, Vos CB, Peterse JL, van de Vijver MJ, Litvinov S, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183:404-11.
25. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, et al. Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 1997;54:158-65.
26. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN, et al. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 1997;182:331-8.
27. Denk C, Hulsken J, Schwarz E. Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett 1997;120:185-93.
28. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer 1996;77:1605-13.
29. Takayama T, Shiozaki H, Doki Y, Oka H, Inoue M, Yamamoto M, et al. Aberrant expression and phosphorylation of β-catenin in human colorectal cancer. Br J Cancer 1998;77: 605-13.
30. Viberti L, Papotti M, Abbona GC, Celano A, Filosso PL, Bussolati G. Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung. Hum Pathol 1997;28: 189-92.
31. Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Cancer 1997;80:1034-45.
32. Harpole DH Jr, Herndon JE 2nd, Wolfe WG, Iglehart JD, Marks JR. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995;55:51-6.
33. Kitamura H, Kameda Y, Nakamura N, Nakatani Y, Inayama Y, Iida M, et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Am J Surg Pathol 1996;20:553-62.